Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.240
+0.060 (1.44%)
At close: Nov 20, 2024, 4:00 PM
4.230
-0.010 (-0.24%)
After-hours: Nov 20, 2024, 5:57 PM EST

Company Description

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.

The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services.

Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant.

The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc.
Aurora Cannabis logo
Country Canada
Founded 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,073
CEO Miguel Martin

Contact Details

Address:
90B Street SW, Suite 2207
Edmonton, AB T6X 1V8
Canada
Phone 855 279 4652
Website auroramj.com

Stock Details

Ticker Symbol ACB
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency CAD
CIK Code 0001683541
CUSIP Number 05156X884
ISIN Number CA05156X8504
SIC Code 2833

Key Executives

Name Position
Miguel Martin Chief Executive Officer and Executive Chairman
Alex Miller Executive Vice President of Operations and Supply Chain
Nathalie Clark Executive Vice President, General Counsel and Corporate Secretary
Andre Jerome Executive Vice President of Global Business Development
Ananth Krishnan Vice President of Capital Markets and Investor Relations
Michelle Lefler Vice President of Communications and Public Relations
Lori Schick Executive Vice President of Human Resources
Dr. Jonathan Page Ph.D. Senior Science Advisor
Rick Savone Senior Vice President of Global Government Relations
David Aird Executive Vice President of Information Technology

Latest SEC Filings

Date Type Title
Nov 6, 2024 6-K Report of foreign issuer
Nov 6, 2024 6-K Report of foreign issuer
Oct 25, 2024 6-K Report of foreign issuer
Sep 20, 2024 S-8 Securities to be offered to employees in employee benefit plans
Sep 20, 2024 6-K Report of foreign issuer
Sep 17, 2024 6-K Report of foreign issuer
Aug 26, 2024 6-K Report of foreign issuer
Aug 12, 2024 6-K Report of foreign issuer
Aug 7, 2024 6-K Report of foreign issuer
Aug 7, 2024 6-K Report of foreign issuer